30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 30 of 30 clinical reviews.
A physician-reviewed guide to the safety, interaction profile, and monitoring considerations for combining 5-HTP with dapagliflozin (Farxiga), covering pharmacokinetics, serotonin syndrome risk, and practical clinical guidance.
A physician-reviewed guide to combining alpha-lipoic acid with Farxiga (dapagliflozin), covering pharmacodynamic interactions, hypoglycemia risk, thyroid effects, monitoring, and clinical safety data.
A board-reviewed clinical guide on combining ashwagandha with dapagliflozin (Farxiga), covering pharmacokinetic and pharmacodynamic interactions, cortisol and thyroid effects, blood glucose overlap, and monitoring recommendations.
Clinical review of the berberine and Farxiga (dapagliflozin) interaction, covering pharmacokinetic overlap, blood-sugar monitoring, dose-separation strategy, and when to tell your prescriber.
A physician-reviewed guide to the caffeine-dapagliflozin interaction: pharmacokinetics, blood glucose effects, blood pressure, dehydration risk, and practical monitoring advice for patients on Farxiga.
A clinician-reviewed guide to the calcium-dapagliflozin interaction: pharmacokinetics, cardiovascular considerations, dosing windows, and monitoring guidance for patients on Farxiga.
A physician-reviewed guide to taking CoQ10 with Farxiga (dapagliflozin), covering pharmacokinetic and pharmacodynamic interactions, safety data, dosing, and monitoring recommendations for patients with type 2 diabetes, heart failure, or CKD.
A physician-reviewed guide to the creatine-dapagliflozin interaction: why creatine raises serum creatinine, how that affects Farxiga monitoring, and what your doctor needs to know before you combine them.
A clinician-reviewed guide to combining folate supplements with Farxiga (dapagliflozin), covering pharmacokinetic interactions, MTHFR status, dosing guidance, and monitoring recommendations.
A detailed clinical review of the ginseng-dapagliflozin interaction: pharmacodynamic blood glucose effects, anticoagulant potentiation, monitoring guidance, and when to call your prescriber.
A clinically detailed look at whether glutathione supplements are safe with dapagliflozin (Farxiga), covering pharmacokinetic interactions, monitoring parameters, and practical dosing guidance reviewed by the HealthRX medical team.
A clinician-reviewed guide to combining glycine supplements with dapagliflozin (Farxiga), covering pharmacokinetic interactions, blood sugar effects, sleep, collagen support, monitoring, and dosing considerations.
A physician-reviewed guide to the green tea extract / EGCG and Farxiga (dapagliflozin) interaction: hepatotoxicity risk, pharmacokinetic mechanisms, safe dosing windows, and monitoring recommendations.
A clinician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction between L-theanine and dapagliflozin (Farxiga), with dosing guidance, monitoring tips, and safety evidence.
A board-reviewed clinical guide covering every known and theoretical interaction between lion's mane mushroom and dapagliflozin (Farxiga), with monitoring advice, dose context, and patient safety steps.
A detailed clinical review of magnesium and dapagliflozin (Farxiga) interactions, safety, dosing, and monitoring for people with type 2 diabetes, heart failure, or CKD.
A physician-reviewed guide covering the melatonin-dapagliflozin interaction, including mechanism, glucose effects, dosing timing, and monitoring recommendations for people on Farxiga.
A physician-reviewed guide to the NAC and Farxiga interaction: pharmacokinetics, pharmacodynamics, potential benefits, real risks, monitoring parameters, and dosing timing advice.
A physician-reviewed guide to combining omega-3 fatty acids (EPA/DHA) with dapagliflozin (Farxiga), covering pharmacokinetic safety, pharmacodynamic interactions, triglyceride effects, bleeding risk, and monitoring recommendations.
Clinician-reviewed guide on taking quercetin with Farxiga (dapagliflozin). Covers CYP3A4 interaction potential, pharmacokinetic data, dose-separation strategies, and monitoring.
A clinician-reviewed guide on the safety, interactions, and monitoring considerations of combining reishi mushroom with dapagliflozin (Farxiga) for type 2 diabetes, heart failure, or CKD.
Evidence-based guide to the resveratrol and Farxiga (dapagliflozin) interaction, covering CYP3A4 metabolism, estrogenic activity, blood sugar effects, dose-separation strategies, and monitoring recommendations.
Evidence-based guide to rhodiola and Farxiga (dapagliflozin) interactions, covering pharmacokinetic and pharmacodynamic concerns, monitoring recommendations, and dose-separation strategies.
A physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interactions between saw palmetto and dapagliflozin (Farxiga), with dosing, monitoring, and safety recommendations.
St. John's Wort accelerates dapagliflozin metabolism through CYP3A4 and UGT1A9 induction, potentially cutting Farxiga blood levels by up to 25% and reducing its glucose-lowering and cardioprotective effects. Learn what the evidence shows and what to do if you are already taking both.
A physician-reviewed guide to the turmeric-dapagliflozin interaction: pharmacokinetics, pharmacodynamics, blood sugar and bleeding risks, dosing separation, and monitoring steps for patients on Farxiga.
A physician-reviewed guide on combining vitamin B12 with Farxiga (dapagliflozin). Learn what the evidence says about interactions, who is at risk, how to dose, and when to test your B12 levels.
A board-reviewed guide on combining vitamin B6 with dapagliflozin (Farxiga): pharmacokinetic and pharmacodynamic interactions, safe dose ranges, neuropathy monitoring, and when to call your prescriber.
A physician-reviewed guide to combining vitamin D supplements with Farxiga (dapagliflozin). Covers the pharmacokinetic interaction profile, bone health, kidney considerations, and dosing guidance for people with type 2 diabetes, heart failure, or CKD.
Evidence-based guide on taking zinc supplements with Farxiga (dapagliflozin). Covers drug-supplement interactions, dose separation, monitoring, and clinical recommendations.